MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,903,218 | +48.1% | 801,268 | +22.8% | 0.02% | +63.6% |
| Q2 2023 | $23,570,839 | -2.8% | 652,390 | +0.0% | 0.01% | -8.3% |
| Q1 2023 | $24,255,056 | -27.3% | 652,368 | -11.5% | 0.01% | -29.4% |
| Q4 2022 | $33,382,958 | -67.3% | 736,768 | -49.5% | 0.02% | -69.6% |
| Q3 2022 | $101,979,000 | +4.2% | 1,460,193 | +0.1% | 0.06% | +14.3% |
| Q2 2022 | $97,907,000 | +3.4% | 1,458,465 | +26.7% | 0.05% | +28.9% |
| Q1 2022 | $94,659,000 | -49.0% | 1,151,281 | -9.0% | 0.04% | -43.3% |
| Q4 2021 | $185,573,000 | -18.2% | 1,265,071 | -1.3% | 0.07% | -21.2% |
| Q3 2021 | $226,756,000 | +12.9% | 1,281,758 | +3.1% | 0.08% | +10.4% |
| Q2 2021 | $200,826,000 | +18.2% | 1,243,269 | +25.3% | 0.08% | +11.6% |
| Q1 2021 | $169,954,000 | +166.5% | 992,143 | +241.7% | 0.07% | +155.6% |
| Q4 2020 | $63,776,000 | +79.3% | 290,365 | +35.5% | 0.03% | +58.8% |
| Q3 2020 | $35,575,000 | -6.3% | 214,244 | -30.7% | 0.02% | -15.0% |
| Q2 2020 | $37,979,000 | +59.8% | 309,171 | 0.0% | 0.02% | +25.0% |
| Q1 2020 | $23,766,000 | -37.8% | 309,171 | +4.2% | 0.02% | -20.0% |
| Q4 2019 | $38,216,000 | +54.1% | 296,571 | -6.8% | 0.02% | +53.8% |
| Q3 2019 | $24,804,000 | -18.1% | 318,371 | +8.3% | 0.01% | -18.8% |
| Q2 2019 | $30,277,000 | -7.2% | 293,951 | -34.0% | 0.02% | -5.9% |
| Q1 2019 | $32,630,000 | +1561.4% | 445,151 | +17.9% | 0.02% | +1600.0% |
| Q1 2017 | $1,964,000 | +9.5% | 377,646 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,794,000 | -55.8% | 377,646 | -38.5% | 0.00% | -50.0% |
| Q3 2016 | $4,059,000 | +21.1% | 613,996 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,352,000 | -74.5% | 613,996 | 0.0% | 0.00% | -71.4% |
| Q1 2016 | $13,140,000 | -32.3% | 613,996 | 0.0% | 0.01% | -30.0% |
| Q4 2015 | $19,402,000 | -16.7% | 613,996 | -9.3% | 0.01% | -16.7% |
| Q3 2015 | $23,290,000 | -10.4% | 676,640 | -18.1% | 0.01% | 0.0% |
| Q2 2015 | $25,989,000 | +10.4% | 825,846 | +2.9% | 0.01% | +9.1% |
| Q1 2015 | $23,539,000 | +50.9% | 802,846 | -4.7% | 0.01% | +57.1% |
| Q4 2014 | $15,600,000 | +2.2% | 842,346 | -3.3% | 0.01% | 0.0% |
| Q3 2014 | $15,257,000 | -26.1% | 871,345 | -15.6% | 0.01% | -22.2% |
| Q2 2014 | $20,645,000 | +21.8% | 1,032,246 | +16.1% | 0.01% | +12.5% |
| Q1 2014 | $16,948,000 | +57.1% | 888,746 | +37.0% | 0.01% | +60.0% |
| Q4 2013 | $10,788,000 | – | 648,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |